File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1182/blood-2003-01-0298
- Scopus: eid_2-s2.0-0037902046
- PMID: 12814916
- WOS: WOS:000183820300066
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia [1]
Title | Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia [1] |
---|---|
Authors | |
Issue Date | 2003 |
Publisher | American Society of Hematology. The Journal's web site is located at http://bloodjournal.hematologylibrary.org/ |
Citation | Blood, 2003, v. 102 n. 1, p. 407-408 How to Cite? |
Persistent Identifier | http://hdl.handle.net/10722/148336 |
ISSN | 2023 Impact Factor: 21.0 2023 SCImago Journal Rankings: 5.272 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Au, WY | en_HK |
dc.contributor.author | Kumana, CR | en_HK |
dc.contributor.author | Kou, M | en_HK |
dc.contributor.author | Mak, R | en_HK |
dc.contributor.author | Chan, GCF | en_HK |
dc.contributor.author | Lam, CW | en_HK |
dc.contributor.author | Kwong, YL | en_HK |
dc.date.accessioned | 2012-05-29T06:12:18Z | - |
dc.date.available | 2012-05-29T06:12:18Z | - |
dc.date.issued | 2003 | en_HK |
dc.identifier.citation | Blood, 2003, v. 102 n. 1, p. 407-408 | en_HK |
dc.identifier.issn | 0006-4971 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/148336 | - |
dc.language | eng | en_US |
dc.publisher | American Society of Hematology. The Journal's web site is located at http://bloodjournal.hematologylibrary.org/ | en_HK |
dc.relation.ispartof | Blood | en_HK |
dc.subject.mesh | Administration, Oral | en_US |
dc.subject.mesh | Adolescent | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use | en_US |
dc.subject.mesh | Arsenicals - Administration & Dosage | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Leukemia, Promyelocytic, Acute - Complications - Drug Therapy | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Oxides - Administration & Dosage | en_US |
dc.subject.mesh | Remission Induction | en_US |
dc.subject.mesh | Salvage Therapy | en_US |
dc.subject.mesh | Treatment Outcome | en_US |
dc.subject.mesh | Tretinoin - Therapeutic Use | en_US |
dc.title | Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia [1] | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Chan, GCF:gcfchan@hkucc.hku.hk | en_HK |
dc.identifier.email | Lam, CW:ching-wanlam@pathology.hku.hk | en_HK |
dc.identifier.email | Kwong, YL:ylkwong@hku.hk | en_HK |
dc.identifier.authority | Chan, GCF=rp00431 | en_HK |
dc.identifier.authority | Lam, CW=rp00260 | en_HK |
dc.identifier.authority | Kwong, YL=rp00358 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1182/blood-2003-01-0298 | en_HK |
dc.identifier.pmid | 12814916 | en_HK |
dc.identifier.scopus | eid_2-s2.0-0037902046 | en_HK |
dc.identifier.hkuros | 86279 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-0037902046&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 102 | en_HK |
dc.identifier.issue | 1 | en_HK |
dc.identifier.spage | 407 | en_HK |
dc.identifier.epage | 408 | en_HK |
dc.identifier.isi | WOS:000183820300066 | - |
dc.publisher.place | United States | en_HK |
dc.identifier.scopusauthorid | Au, WY=7202383089 | en_HK |
dc.identifier.scopusauthorid | Kumana, CR=7005112381 | en_HK |
dc.identifier.scopusauthorid | Kou, M=7004545950 | en_HK |
dc.identifier.scopusauthorid | Mak, R=7004972794 | en_HK |
dc.identifier.scopusauthorid | Chan, GCF=16160154400 | en_HK |
dc.identifier.scopusauthorid | Lam, CW=34570692600 | en_HK |
dc.identifier.scopusauthorid | Kwong, YL=7102818954 | en_HK |
dc.identifier.issnl | 0006-4971 | - |